Alex Belov
Developers by oneinveststock.com. Analyst, investor
Netflix (NFLX) Stock Price Today, Real-Time Quotes, Forecasts
Netflix (NFLX) Stock: Real Time Chart and Quotes
Stock Consensus Rating = "Buy"
Lowest Price Target
$200.00
Average target price
$331.00
Maximum target price
$417.00
Netflix
NFLX
Stock = Netflix
ISIN = US64110L1061
About company = Today, Netflix is the largest provider of movies and series based on streaming media. The company was founded in 1997. The headquarters is located in California. Netflix releases more than 100 movies and TV series every year. More than 100 million people have subscribed to paid subscriptions.
Netflix (NFLX) Stock Forecasts and Target Prices for 2023
On January 20, 2023 analytical firm “Baird” published a latest price target for Netflix Inc (NFLX) stock of $325,00 for the next 12 months. 100 analyst firms have released forecasts for Netflix Inc (NFLX) stock over the past year. The consensus rating of analytical firms is “Buy”. The average analyst price target is $331.00 over the next 12 months. See the table below for the latest price targets and analyst forecasts for Netflix Inc (NFLX) shares.
Netflix (NFLX) Latest Price Targets
| Forecast date | Analytical firm | Change target price | Rating |
|---|---|---|---|
| 01/20/2023 | Baird | $275→$325 | Neutral |
| 01/20/2023 | Credit Suisse | $271→$291 | Neutral |
| 01/20/2023 | Barclays | $235→$250 | Equal-Weight |
| 01/20/2023 | JP Morgan | $330→$390 | Overweight |
| 01/20/2023 | Oppenheimer | $400→$415 | Outperform |
| 01/20/2023 | Wolfe Research | $366→$417 | Outperform |
| 01/20/2023 | Benchmark | $225→$250 | Sell |
| 01/20/2023 | Evercore ISI Group | $340→$400 | Outperform |
| 01/20/2023 | Guggenheim | $305→$375 | Buy |
| 01/20/2023 | Jefferies | $385→$400 | Buy |
| 01/20/2023 | Rosenblatt | $226→$343 | Neutral |
| 01/20/2023 | Piper Sandler | $270→$325 | Neutral |
| 01/20/2023 | Canaccord Genuity | $365→$400 | Buy |
| 01/20/2023 | Morgan Stanley | $300→$350 | Equal-Weight |
| 01/19/2023 | Morgan Stanley | $275→$300 | Equal-Weight |
| 01/17/2023 | Wedbush | $325→$400 | Outperform |
| 01/17/2023 | UBS | $250→$350 | Neutral |
| 01/17/2023 | Truist Securities | $210→$339 | Hold |
| 01/13/2023 | Oppenheimer | $365→$400 | Outperform |
| 01/12/2023 | Jefferies | $310→$385 | Buy |
| 01/10/2023 | Goldman Sachs | $200 →$225 | Sell |
| 01/04/2023 | New Street Research | $304 | Neutral |
| 12/29/2022 | CFRA | $310 | Buy |
| 10/25/2022 | Daiwa Capital | $226→$330 | Outperform |
| 10/19/2022 | Benchmark | $157→$162 | Sell |
| 10/19/2022 | Wedbush | $280→$325 | Outperform |
| 10/19/2022 | Deutsche Bank | → $350 | Buy |
| 10/19/2022 | Cowen & Co. | $325→$340 | Outperform |
| 10/19/2022 | Barclays | $170→$235 | Equal-Weight |
| 10/19/2022 | Oppenheimer | $325→$365 | Outperform |
| 10/19/2022 | Credit Suisse | $263→$271 | Neutral |
| 10/19/2022 | Rosenblatt | $201→$226 | Neutral |
| 10/19/2022 | Pivotal Research | $175→$200 | Sell |
| 10/19/2022 | Macquarie | $230→$285 | Neutral |
| 10/19/2022 | Piper Sandler | $215→$270 | Neutral |
| 10/19/2022 | Morgan Stanley | $230→$250 | Equal-Weight |
| 10/19/2022 | JP Morgan | $240→$330 | Overweight |
| 10/14/2022 | UBS | $198→$250 | Neutral |
| 09/28/2022 | Atlantic Equities | $211→$283 | Overweight |
| 09/19/2022 | Oppenheimer | → $325 | Outperform |
| 09/16/2022 | Citigroup | $275→$305 | Buy |
| 09/15/2022 | Evercore ISI Group | $245→$300 | Outperform |
| 09/07/2022 | Macquarie | $170→$230 | Neutral |
| 09/07/2022 | Jefferies | $243→$230 | Hold |
| 08/22/2022 | CFRA | $245→$238 | Sell |
| 07/20/2022 | Morgan Stanley | $220→$230 | Equal-Weight |
| 07/20/2022 | Rosenblatt | $196→$201 | Neutral |
| 07/20/2022 | Macquarie | $150→$170 | Underperform |
| 07/20/2022 | Baird | $260→$240 | Neutral |
| 07/20/2022 | JP Morgan | $230→$240 | Neutral |
| 07/20/2022 | Deutsche Bank | $300→$270 | Hold |
| 07/20/2022 | Credit Suisse | $350→$263 | Neutral |
| 07/20/2022 | Pivotal Research | $235→$175 | Sell |
| 07/20/2022 | Piper Sandler | $210→$215 | Neutral |
| 07/20/2022 | Stifel | $240→$250 | Hold→Buy |
| 07/18/2022 | Rosenblatt | $245→$196 | Neutral |
| 07/15/2022 | UBS | $355→$198 | Neutral |
| 07/14/2022 | BMO Capital | $405→$365 | Outperform |
| 07/12/2022 | Morgan Stanley | $300→$220 | Equal-Weight |
| 07/07/2022 | Evercore ISI Group | $300→$245 | In-Line |
| 07/07/2022 | Citigroup | $295→$275 | Buy |
| 07/06/2022 | Barclays | $275→$170 | Equal-Weight |
| 07/05/2022 | Piper Sandler | $293→$210 | Neutral |
| 07/01/2022 | Truist Securities | $300 →$210 | Hold |